AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24193155 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg induction infusions at weeks 0, 2, and 6
Number of subjects: 60
Study 24193155 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg every 8 weeks (q8w)
Number of subjects: 60
Study 24193155 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 10 mg/kg
Number of subjects: 60
Study 20735290 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg
Number of subjects: 183
Study 20735290 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg
Number of subjects: 183
Study 20735290 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 100 mg
Number of subjects: 183
Study 20735290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 18489775 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei rhamnosus) administered at 10^9 colony-forming units twice daily from day 3 to discharge
Number of subjects: 208
Study 18489775 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei rhamnosus)
Number of subjects: 208
Study 18489775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 15899078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse clinic
Number of subjects: 245
Study 15899078 — intervention group
Group type: COMPARATOR
Intervention: Doctor clinic
Number of subjects: 245
Study 12435983 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 60
Study 10347518 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental alternating air device
Number of subjects: 217
Study 10347518 — intervention group
Group type: COMPARATOR
Intervention: Conventional practice (Control)
Number of subjects: 217
Study 10347518 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 217
Study 7572708 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta formula (triacylglycerols resembling the stereoisomeric structure of human milk fat, 25.4% by wt 16:0, 76.1% at the sn-2 position)
Number of subjects: 7
Study 7572708 — intervention group
Group type: COMPARATOR
Intervention: Alpha formula (87.3% of total 16:0, 25.7% by wt at the sn-1,3 positions)
Number of subjects: 7
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐methasone‐17‐valerate
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednicarbate (two concentrations)
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol‐17‐propionate
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone‐17,21‐dipropionate
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone (DOM) in different biopharmaceutical forms
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: DOM gel
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointments
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Creams
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Gels
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual scores
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin colorimetry
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia after arterial occlusion
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting skin blood flow in inflamed skin
Number of subjects: 30
Study 1768431 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in temperature of inflamed skin
Number of subjects: 30
Study 7129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-movement jump (CMJ) with active stretching of calf muscles before concentric work
Number of subjects: 5
Study 7129720 — intervention group
Group type: COMPARATOR
Intervention: Pure concentric contraction (SJ)
Number of subjects: 5
Study 7129720 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG recording during CMJ
Number of subjects: 5
Study 31513849 — intervention group
Group type: EXPERIMENTAL
Intervention: WM updating training (adaptive dual n-back task)
Number of subjects: 40
Study 31513849 — intervention group
Group type: COMPARATOR
Intervention: Active control (computer game)
Number of subjects: 40
Study 28099699 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic hysterectomy
Number of subjects: 144
Study 28099699 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopic hysterectomy
Number of subjects: 144
Study 25712532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (wine)
Number of subjects: 28
Study 25712532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (vodka)
Number of subjects: 28
Study 25712532 — intervention group
Group type: EXPERIMENTAL
Intervention: Dealcoholized wine
Number of subjects: 28
Study 25712532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24875964 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (NE) plus usual care (UC)
Number of subjects: 67
Study 24875964 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 67
Study 21789590 — intervention group
Group type: EXPERIMENTAL
Intervention: S(3) Bond (Kuraray Corp., Japan) with Clearfil ST resin composite
Number of subjects: 11
Study 21789590 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐Bond (GC Corp., Japan) with Gradia resin composite
Number of subjects: 11
Study 20025139 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple phototherapy
Number of subjects: 40
Study 20025139 — intervention group
Group type: COMPARATOR
Intervention: Double phototherapy
Number of subjects: 40
Study 17446812 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (n=11; 100% of peak work rate for 30 s, alternating with 30 s-rest)
Number of subjects: 21
Study 17446812 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous training (n=10; 50% of peak work rate)
Number of subjects: 21
Study 15539725 — intervention group
Group type: EXPERIMENTAL
Intervention: FANO in patients with PBC associated with SS (mean 8.9 ± 0.8 ppb)
Number of subjects: 34
Study 15539725 — intervention group
Group type: EXPERIMENTAL
Intervention: FANO in patients with PBC not associated with SS (mean 7.7 ± 0.7 ppb)
Number of subjects: 34
Study 15539725 — intervention group
Group type: EXPERIMENTAL
Intervention: FANO in cirrhotic patients with increased P(A-a)O(2) (mean 9.8 ± 0.8 ppb)
Number of subjects: 34
Study 15539725 — intervention group
Group type: EXPERIMENTAL
Intervention: QbrNO in patients with primary SS and SS associated with PBC
Number of subjects: 34
Study 15539725 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (healthy controls)
Number of subjects: 34
Study 15539725 — intervention group
Group type: COMPARATOR
Intervention: Patients with primary SS
Number of subjects: 34
Study 11429344 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (initial dose of 10 mg/kg and infusion of 1 mg/kg/h)
Number of subjects: 40
Study 11429344 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 40
Study 10937295 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological awareness
Number of subjects: 0
Study 10937295 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid naming
Number of subjects: 0
Study 10937295 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral decoding of words and pseudowords
Number of subjects: 0
Study 10937295 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoword reading
Number of subjects: 0
Study 9305673 — intervention group
Group type: EXPERIMENTAL
Intervention: CIFN 9 microg
Number of subjects: 704
Study 9305673 — intervention group
Group type: EXPERIMENTAL
Intervention: CIFN 3 microg
Number of subjects: 704
Study 9305673 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa‐2b 3 MU
Number of subjects: 704
Study 9305673 — intervention group
Group type: EXPERIMENTAL
Intervention: CIFN 15 microg
Number of subjects: 704
Study 8452273 — intervention group
Group type: EXPERIMENTAL
Intervention: VCRII technique using 4.5% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64
Study 8452273 — intervention group
Group type: COMPARATOR
Intervention: Conventional spontaneous inhalation induction technique using 4.5% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64
Study 3699074 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 2
Study 3699074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 31881929 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation via cryoablation (Cryo-RDN)
Number of subjects: 0
Study 29277689 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet Nebulizer (JN)
Number of subjects: 10
Study 29277689 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-Enhanced Nebulizer (BEN)
Number of subjects: 10
Study 29277689 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating Mesh Nebulizer (VMN)
Number of subjects: 10
Study 29277689 — intervention group
Group type: EXPERIMENTAL
Intervention: Manually Triggered Nebulizer (MTN)
Number of subjects: 10
Study 29277689 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-Actuated Nebulizer (BAN)
Number of subjects: 10
Study 27405396 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding intervention promoted by peer counsellors during the first 6 months of infancy
Number of subjects: 765
Study 24169807 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin added to sulphonylurea
Number of subjects: 619
Study 24169807 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to sulphonylurea
Number of subjects: 619
Study 21707252 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-assisted coping planning intervention
Number of subjects: 86
Study 21707252 — intervention group
Group type: COMPARATOR
Intervention: Self-administered coping planning intervention
Number of subjects: 86
Study 21707252 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping plans formulated
Number of subjects: 86
Study 21707252 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-pursuit strategies (optimisation and compensation)
Number of subjects: 86
Study 21707252 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping plans and goal-pursuit strategies interaction
Number of subjects: 86
Study 20629867 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO(2)) treatment (0% at 96 h, 60% at 48 h, and 60% at 96 h)
Number of subjects: 0
Study 20629867 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (O(3)) treatment (0 and 175 ppm for 48 h)
Number of subjects: 0
Study 20629867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 18589630 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute psychiatric day care
Number of subjects: 0
Study 18589630 — intervention group
Group type: COMPARATOR
Intervention: Inpatient care
Number of subjects: 0
Study 18589630 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic and clinical characteristics analysis
Number of subjects: 0
Study 15844692 — intervention group
Group type: EXPERIMENTAL
Intervention: OACA (omeprazole‐amoxicillin‐clarithromycin + aspirin)
Number of subjects: 121
Study 15844692 — intervention group
Group type: COMPARATOR
Intervention: OAC (omeprazole‐amoxicillin‐clarithromycin)
Number of subjects: 121
Study 12433016 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered educational and behavioral intervention
Number of subjects: 34
Study 12433016 — intervention group
Group type: COMPARATOR
Intervention: Standard-treatment (education) control group
Number of subjects: 34
Study 12433016 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 10069685 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine, 4 mg
Number of subjects: 29
Study 10069685 — intervention group
Group type: COMPARATOR
Intervention: Short-acting nifedipine, 20 mg
Number of subjects: 29
Study 7628131 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 10 mg PO QPM
Number of subjects: 343
Study 7628131 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg PO QAM
Number of subjects: 343
Study 7628131 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg PO QPM
Number of subjects: 343
Study 7628131 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 343
Study 1838693 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg cilazapril
Number of subjects: 42
Study 1838693 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg cilazapril
Number of subjects: 42
Study 1838693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30303061 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 90
Study 30303061 — intervention group
Group type: COMPARATOR
Intervention: Mentalisation-based therapy (MBT)
Number of subjects: 90
Study 27609792 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluciclovine PET/CT
Number of subjects: 96
Study 27609792 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging (CT and MRI)
Number of subjects: 96
Study 26558544 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily (q.d.) lopinavir/ritonavir
Number of subjects: 173
Study 26558544 — intervention group
Group type: COMPARATOR
Intervention: Twice daily (b.i.d.) lopinavir/ritonavir
Number of subjects: 173
Study 23646932 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG-augmented diode laser treatment (ICG+DL) with λem = 810 nm, 60-110 J cm(‐2), 48-87-ms pulse duration, 6-mm spot size; total ICG dose 4 mg kg(‐1)
Number of subjects: 29
Study 23646932 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser treatment with λem = 1064 nm, 160-240 J cm(‐2), 65-ms pulse duration, 5-mm spot size
Number of subjects: 29
Study 21468375 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucous resection of a hypertrophied inferior turbinate together with septoplasty (Group A)
Number of subjects: 42
Study 21468375 — intervention group
Group type: COMPARATOR
Intervention: Septoplasty only (Group B)
Number of subjects: 42
Study 18068828 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Frail Scale (EFS) score of 3 or less
Number of subjects: 125
Study 18068828 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Frail Scale (EFS) score exceeding 7
Number of subjects: 125
Study 18163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT)
Number of subjects: 89
Study 18163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy (local laboratory)
Number of subjects: 89
Study 18163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy (reference laboratory)
Number of subjects: 89
Study 18163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical diagnosis (all symptoms)
Number of subjects: 89
Study 18163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical diagnosis (fever alone)
Number of subjects: 89
Study 15194018 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of 10/10 mg ezetimibe + simvastatin
Number of subjects: 788
Study 15194018 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of 10/80 mg ezetimibe + simvastatin
Number of subjects: 788
Study 11464718 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin levels measured at 8 a.m.
Number of subjects: 0
Study 9568167 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of G‐CSF and GM‐CSF at 10 mcg/kg/day (2.5 or 5.0 mcg/kg twice per day)
Number of subjects: 0
Study 9568167 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with G‐CSF or GM‐CSF at 5 mcg/kg/day
Number of subjects: 0
Study 9568167 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with G‐CSF or GM‐CSF at 10 mcg/kg/day
Number of subjects: 0
Study 8041179 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (300 mg dl-alpha-tocopherol 3 times daily for 4 weeks)
Number of subjects: 18
Study 8041179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8041179 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin E and Placebo)
Number of subjects: 18
Study 2594875 — intervention group
Group type: EXPERIMENTAL
Intervention: amitriptyline
Number of subjects: 45
Study 2594875 — intervention group
Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 45
Study 1200770 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapists
Number of subjects: 60
Study 1200770 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapists
Number of subjects: 60
Study 31820131 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release (MR) drug product with a proposed change in dissolution specification; specific dosage and duration not available.
Number of subjects: 0
Study 31820131 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical formulation with 0% of drug dissolved in 2 hours in in vitro dissolution test; specific dosage and duration not available.
Number of subjects: 0
Study 31820131 — intervention group
Group type: EXPERIMENTAL
Intervention: PBPK absorption model; specific dosage and duration not available.
Number of subjects: 0
Study 30221578 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive computerized cognitive flexibility training (frequent or infrequent switching)
Number of subjects: 0
Study 30221578 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study 29045327 — intervention group
Group type: EXPERIMENTAL
Intervention: Young women in dry heat (35°C, 20% relative humidity)
Number of subjects: 20
Study 29045327 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women in dry heat (35°C, 20% relative humidity)
Number of subjects: 20
Study 29045327 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women in humid heat (35°C, 60% relative humidity)
Number of subjects: 20
Study 25916595 — intervention group
Group type: EXPERIMENTAL
Intervention: Air temperature at 32 °C with relative humidity greater than 57.8%
Number of subjects: 68
Study 25916595 — intervention group
Group type: COMPARATOR
Intervention: Air temperature at 24 °C
Number of subjects: 68
Study 25916595 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of physical activity (<4 times per week)
Number of subjects: 68
Study 25916595 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress
Number of subjects: 68
Study 24460248 — intervention group
Group type: EXPERIMENTAL
Intervention: BSE education from healthcare professionals
Number of subjects: 0
Study 24460248 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21921700 — intervention group
Group type: EXPERIMENTAL
Intervention: Indian tetravalent vaccine (Q-Vac (TM))
Number of subjects: 287
Study 21921700 — intervention group
Group type: EXPERIMENTAL
Intervention: European tetravalent vaccine (Tritanrix-HB (TM))
Number of subjects: 287
Study 19697853 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphotrophic chemoimmunotherapy with roncoleukin
Number of subjects: 0
Study 17039460 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomalt (30 g per day)
Number of subjects: 19
Study 17039460 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (30 g per day)
Number of subjects: 19
Study 14977341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anaesthesia with propofol-remifentanil
Number of subjects: 120
Study 14977341 — intervention group
Group type: COMPARATOR
Intervention: Balanced anaesthesia with isoflurane-alfentanil
Number of subjects: 120
Study 14977341 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Recovery score and patient satisfaction
Number of subjects: 120
Study 10700773 — intervention group
Group type: EXPERIMENTAL
Intervention: Active enforcement of DVT prophylaxis protocol
Number of subjects: 0
Study 10700773 — intervention group
Group type: COMPARATOR
Intervention: Non-enforced DVT prophylaxis protocol
Number of subjects: 0
Study 9328361 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 30
Study 9328361 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 30
Study 7691912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 12
Study 7691912 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 12
Study 7691912 — intervention group
Group type: COMPARATOR
Intervention: Placebo transdermal nicotine
Number of subjects: 12
Study 2430512 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day therapy with nalidixic acid
Number of subjects: 35
Study 2430512 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day therapy with trimethoprim/sulphamethoxazole
Number of subjects: 35
Study 2430512 — intervention group
Group type: COMPARATOR
Intervention: 10-day therapy with nalidixic acid
Number of subjects: 35
Study 2430512 — intervention group
Group type: COMPARATOR
Intervention: 10-day therapy with trimethoprim/sulphamethoxazole
Number of subjects: 35
Study 2430512 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term treatment (3-day)
Number of subjects: 35
Study 2430512 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (10-day)
Number of subjects: 35
Study 31122495 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB092 150 mg
Number of subjects: 48
Study 31122495 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB092 700 mg
Number of subjects: 48
Study 31122495 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB092 2100 mg
Number of subjects: 48
Study 31122495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 28549427 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk about Children
Number of subjects: 192
Study 28549427 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 192
Study 26494856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose FOLFIRI plus bevacizumab (every 2 weeks) in group 1 (UGT1A1 *1/*1)
Number of subjects: 86
Study 26494856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose FOLFIRI plus bevacizumab (every 2 weeks) in group 2 (UGT1A1 *1/*28)
Number of subjects: 86